RNAM NASDAQ
San Diego, CA 92121
US
Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| McCarthy Teresa | D-Return | 78,000 | $10.16 | 2026-02-27 |
| McCarthy Teresa | D-Return | 165,296 | — | 2026-02-27 |
| McCarthy Teresa | D-Return | 106,000 | $29.00 | 2026-02-27 |
| McCarthy Teresa | D-Return | 65,000 | $22.34 | 2026-02-27 |
| McCarthy Teresa | D-Return | 50,000 | $31.42 | 2026-02-27 |